Trending...
- Dennis Mukeera and Bridget Namubiru Release New Urban Fantasy Novel: Borrowed Destiny
- The Dancing Caravan comes to ArtsWestchester's Gallery
- Franklin Resources, Inc. (BEN) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
NEW YORK, Nov. 20, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that it has elected to extend the date by which it has to consummate a business combination from November 30, 2020 to May 29, 2021 (the "Extension").
At a special meeting (the "Special Meeting") of shareholders held on November 20, 2020, the Company's shareholders approved an amendment to the Company's charters to effect the Extension and subsequently, the Company filed the amendment to its charters with the Registry of Corporate Affairs in the British Virgin Islands.
As a result, the Company now has until May 29, 2021 to consummate its proposed business combination with 4D Pharma PLC ("4D") that it announced in its Form 8-K filed with the Securities and Exchange Commission on October 22, 2020 (the "Merger"), thereby allowing sufficient time for satisfaction of the remaining conditions to the Merger, including 4D's filing of a registration statement on Form F-4 (the "Registration Statement") in order to allow 4D to apply to admit its American Depositary Shares for trading on NASDAQ and the convening of a shareholder meeting of both the Company's shareholders and 4D's shareholders.
More on Nyenta.com
About LOAC
LOAC is a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities. LOAC is contemplating a proposed business combination with 4D Pharma PLC, a public limited company incorporated under the laws of England and Wales pursuant to an agreement and plan of merger dated October 21, 2020 as disclosed in a Form 8-K filed with the Securities and Exchange Commission on October 22, 2020. LOAC is sponsored by Whale Management Corporation, a BVI business company with limited liability.
Forward-Looking Statements
This press release and the exhibits hereto include "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any actual results may differ from expectations, estimates and projections presented or implied and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, LOAC's expectations with respect to future performance, anticipated financial impacts of the proposed business combination, approval of the business combination transactions by security holders, the satisfaction of the closing conditions to such transactions and the timing of the completion of such transactions.
More on Nyenta.com
Contact:
Matthew Chen
Longevity Acquisition Corporation
+ (86) 21-60832028
[email protected]
SOURCE Longevity Acquisition Corporation
At a special meeting (the "Special Meeting") of shareholders held on November 20, 2020, the Company's shareholders approved an amendment to the Company's charters to effect the Extension and subsequently, the Company filed the amendment to its charters with the Registry of Corporate Affairs in the British Virgin Islands.
As a result, the Company now has until May 29, 2021 to consummate its proposed business combination with 4D Pharma PLC ("4D") that it announced in its Form 8-K filed with the Securities and Exchange Commission on October 22, 2020 (the "Merger"), thereby allowing sufficient time for satisfaction of the remaining conditions to the Merger, including 4D's filing of a registration statement on Form F-4 (the "Registration Statement") in order to allow 4D to apply to admit its American Depositary Shares for trading on NASDAQ and the convening of a shareholder meeting of both the Company's shareholders and 4D's shareholders.
More on Nyenta.com
- CCHR Seeks Redress for Those Forcibly Held and Harmed in Behavioral Facilities
- BrickHouse Ceramic Art Center 2024 Annual Holiday Craft Show
- New Rochelle: Applications Now Available for Little Hoopers 2024 Basketball Clinic
- New Rochelle Parks and Recreation presents the 2024 Pickleball Tournament
- DocVilla Unveils AI and Automation in Cloud-Based EHR Software, Revolutionizing Healthcare Delivery
About LOAC
LOAC is a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities. LOAC is contemplating a proposed business combination with 4D Pharma PLC, a public limited company incorporated under the laws of England and Wales pursuant to an agreement and plan of merger dated October 21, 2020 as disclosed in a Form 8-K filed with the Securities and Exchange Commission on October 22, 2020. LOAC is sponsored by Whale Management Corporation, a BVI business company with limited liability.
Forward-Looking Statements
This press release and the exhibits hereto include "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any actual results may differ from expectations, estimates and projections presented or implied and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, LOAC's expectations with respect to future performance, anticipated financial impacts of the proposed business combination, approval of the business combination transactions by security holders, the satisfaction of the closing conditions to such transactions and the timing of the completion of such transactions.
More on Nyenta.com
- INVESTIGATION: The M&A Class Action Firm Investigates the Merger and Imminent Vote on September 20, 2024, of Squarespace, Inc. - SQSP
- DocVilla Introduces Best All-in-One Customizable Cloud-Based EHR Practice Management Software for Multi-Specialty and Small Practices
- 9/11 Remembrance Ceremonies in New Rochelle
- Life with Lucia and Glynn: A Global Duo Spreading Joy Through Matching Shirts and Adventures
- Luxury Real Estate Agent James Edmunds lists luxury beach home in the heart of Deerfield Beach
Contact:
Matthew Chen
Longevity Acquisition Corporation
+ (86) 21-60832028
[email protected]
SOURCE Longevity Acquisition Corporation
Filed Under: Business
0 Comments
Latest on Nyenta.com
- Daniel Harel Opposes New School Policy on Lice Screenings, Warns of Risk to Students' Well-being
- HBCU New York Classic Makes History with First-Ever Divine Nine Stroll Line
- Pathways to Peace to launch proactive, case-management outreach model in Rochester City Schools
- Wordeee Publishes Kamau Ptah's, Crossing the Threshold; Embracing the Call
- The Demex Group Raises $10.25 Million to Address Growing Demand for its Breakthrough Weather- and Climate-related Reinsurance Solution
- Creative Biolabs presents codes ruling antibody discovery
- Entertainer Russell Moss Brings Two Nights Of Cool To New York's Triad Theater
- Don't Let The Pigeon Drive The Bus! The Musical! Flies Into To Tribeca PAC
- TalentWell Launches Next Generation of AI-powered Talent Sourcing with Automated, Personalized Videos
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- EIU strengthens leadership team and names Constance Hunter as chief economist
- Complete DataBase Package Passports, ID card, SSN card, DL, Birth Certificates
- SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP
- Cboe Global Markets to Present at the Barclays Global Financial Services Conference on September 9
- L-Tron announces OSCR360 Tablet Software release v.2024.94.0
- OSCR360 featured at NYS Police FIU exhibit at the NY State Fair for Second Year
- Tutanota LLC Amends Tender Offer for up to 1,000,000 Shares of Intel Corporation
- Dr. Seth Chambers Shares Journey to Success in Implant Dentistry on Unofficial Podcast's Summer Series: "Mind, Body, & Arches"
- Datavalet is a Great Place to Work for the Second Year in a Row
- Health is for EveryBODY™ Campaign Partners with Chip In™